Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis

SIMPLE SUMMARY: The current guidelines suggest that concurrent chemoradiotherapy (CCRT) with a cisplatin-based regimen is the standard treatment for patients with nonmetastatic NPC. However, little is known regarding the addition of tegafur–uracil (UFUR) to CCRT in patients with NPC. Our study showe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lien, Ching-Feng, Wang, Chien-Chung, Yang, Chuan-Chien, Wang, Chih-Chun, Hwang, Tzer-Zen, Shih, Yu-Chen, Yeh, Shyh-An, Hsieh, Meng-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496885/
https://www.ncbi.nlm.nih.gov/pubmed/36139674
http://dx.doi.org/10.3390/cancers14184511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496885/
https://www.ncbi.nlm.nih.gov/pubmed/36139674
http://dx.doi.org/10.3390/cancers14184511

Ejemplares similares